SCHEMBL21067424

SCHEMBL21067424

CC(C)O[P@@](=O)(O)OC[C@@H](N)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
P2RY10 O00398 9/20 0.47
GPR34 Q9UPC5 4/20 0.47
GPR174 Q9BXC1 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910884 0.81 P2RY10 (0.49) P2RY10GPR34GPR174
SCHEMBL5664175 0.81 P2RY10 (0.43) P2RY10GPR34GPR174
SCHEMBL28350789 0.80 P2RY10 (0.55) P2RY10GPR34GPR174
SCHEMBL1254622 0.79 P2RY10 (0.47) P2RY10GPR34GPR174
SCHEMBL10013705 0.79 P2RY10 (0.51) P2RY10GPR34GPR174
SCHEMBL12888695 0.79 P2RY10 (0.45) P2RY10GPR34GPR174
SCHEMBL12873355 0.78 LAP3 (0.54) P2RY10GPR34GPR174
SCHEMBL17927564 0.78 P2RY10 (0.46) P2RY10GPR34GPR174
SCHEMBL12609430 0.77 P2RY10 (0.44) P2RY10GPR34GPR174
SCHEMBL15127112 0.77 P2RY10 (0.49) P2RY10GPR34GPR174

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed